Industry Insights

  1. Patient-Centric Drug Design — A Clinical And Academic Perspective

    Most issues in pediatric drug development arise from the fact that drugs are traditionally developed for adults and not children. Dr. Meyers shares the hurdles and  improvements in pediatric drug development.

  2. Tips On Selecting A Liquid Chromatography Resin

    There is a wide array of chromatography resins available to address the evolving needs of researchers purifying a diverse set of target molecules.

  3. Why Early Investment In A Scalable Manufacturing Process Is Critical

    The failure of drug compounds in mid- to late-stage development is far more common than anyone would like it to be. Only about 30% of compounds successfully transition from Phase II to Phase III.

  4. Flexible Mobile Biocontainment Units Prevent Spread Of Transmissible Diseases

    There exists two key methods for controlling serious outbreaks of transmissible diseases: therapeutic countermeasures and transmission control through isolation and containment.

  5. Viral Safety Approaches For Advanced Therapy Medicinal Products

    Manufacturers safeguard biologic materials during the development process through a set of measures commonly referred to as the “Safety Tripod.”

  6. Batch And Fed Batch Culture — Practical Steps For Better Results

    Design of Experiments (DoE) mathematical models can help create the perfect environment for batch and fed batch cultures. Understanding the different criteria  and their interactions with each other can be a key differentiator in the race to get your drug to market. 

  7. Electronic Lab Notebook Supports Scientific Knowledge Management In R&D

    One tool holds a unique position among R&D informatics systems -- electronic laboratory notebooks (ELNs). ELNs both produce data and consume information and are particularly powerful.

  8. Business and Cultural Considerations When Managing Clinical Supplies for Asia-Pacific Studies

    In addition to careful adherence with all applicable regulatory and Customs requirements, sponsors should understand and be sensitive to the cultural and business norms of each country included in their study.

  9. Choosing Your Single-Use Technology Supplier

    To be credible, a partner needs to be able to provide technical and regulatory insight, understand your processing needs, be experienced in facility design, and provide advanced operator training.

  10. A Call To Action For Pharma CMOs

    The traditional CMO business model, with multiple clients sharing the same tightly scheduled production trains, is not adaptive; it is a one-size-fits-all solution.